116 related articles for article (PubMed ID: 1380860)
1. Neonatal plasma concentrations of secretory leucocyte protease inhibitor.
Sveger T; Ohlsson K; Svenningsen N
Acta Paediatr; 1992 Mar; 81(3):270-1. PubMed ID: 1380860
[No Abstract] [Full Text] [Related]
2. Protease inhibitors in bronchoalveolar lavage fluid from neonates with special reference to secretory leukocyte protease inhibitor.
Ohlsson K; Sveger T; Svenningsen N
Acta Paediatr; 1992 Oct; 81(10):757-9. PubMed ID: 1384826
[TBL] [Abstract][Full Text] [Related]
3. Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia.
Watterberg KL; Carmichael DF; Gerdes JS; Werner S; Backstrom C; Murphy S
J Pediatr; 1994 Aug; 125(2):264-9. PubMed ID: 7913723
[TBL] [Abstract][Full Text] [Related]
4. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid.
Sathe S; Sakata M; Beaton AR; Sack RA
Curr Eye Res; 1998 Apr; 17(4):348-62. PubMed ID: 9561826
[TBL] [Abstract][Full Text] [Related]
5. The contents of macromolecule solutes in flexor tendon sheath fluid and their relation to synovial fluid. A quantitative analysis.
Hagberg L; Heinegård D; Ohlsson K
J Hand Surg Br; 1992 Apr; 17(2):167-71. PubMed ID: 1375257
[TBL] [Abstract][Full Text] [Related]
6. Contribution of additional elastase inhibitors other than alpha 1-protease inhibitor and bronchial antileukoprotease to neutrophil elastase inhibiting capacity of bronchoalveolar lavage.
Abboud R; Tsang A; Taller M
Ann N Y Acad Sci; 1991; 624():315. PubMed ID: 2064232
[No Abstract] [Full Text] [Related]
7. Studies on the interaction between leukocyte elastase, antileukoproteinase and the plasma proteinase inhibitors alpha 1-proteinase inhibitor and alpha 2-macroglobulin.
Fryksmark U; Ohlsson K; Rosengren M; Tegner H
Hoppe Seylers Z Physiol Chem; 1983 Jul; 364(7):793-800. PubMed ID: 6194094
[TBL] [Abstract][Full Text] [Related]
8. Tissue and plasma elastase and anti-protease (alpha 1 protease inhibitor-alpha 2 macroglobulin) levels in malignancies of head and neck.
Kirkali G; Baskin Y; Güner G; Sengör T; Ceryan K
Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):307S. PubMed ID: 7693524
[No Abstract] [Full Text] [Related]
9. Sera and leukocyte elastase-type protease and antiprotease activity in healthy and atherosclerotic subjects of various ages.
Mohácsi A; Fülöp T; Kozlovszky B; Hauck M; Kiss I; Leövey A
J Gerontol; 1992 Sep; 47(5):B154-8. PubMed ID: 1380968
[TBL] [Abstract][Full Text] [Related]
10. Plasma neutrophil elastase alpha-1-proteinase inhibitor levels in premature neonates with coagulase-negative staphylococcal bacteremia.
Kite P; Todd NJ; MacKay P; Millar MR
J Pediatr; 1990 Oct; 117(4):630-1. PubMed ID: 2213393
[No Abstract] [Full Text] [Related]
11. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates.
Groneck P; Götze-Speer B; Oppermann M; Eiffert H; Speer CP
Pediatrics; 1994 May; 93(5):712-8. PubMed ID: 8165067
[TBL] [Abstract][Full Text] [Related]
12. Secretory leucocyte proteinase inhibitor: inhibition of fibronectin degradation by neutrophil elastase.
Gervaix A; Thompson R; Bieth JG; Nick HP; Suter S
Eur Respir J; 1992 May; 5(5):566-75. PubMed ID: 1351853
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation.
Winklhofer-Roob BM; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Suter S; Shmerling DH
Pediatr Res; 1996 Jul; 40(1):130-4. PubMed ID: 8798258
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil elastase in the diagnosis of neonatal infection.
Philip AG; Tito AM; Gefeller O; Speer CP
Pediatr Infect Dis J; 1994 Apr; 13(4):323-6. PubMed ID: 8036053
[No Abstract] [Full Text] [Related]
15. Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.
Merritt TA; Cochrane CG; Holcomb K; Bohl B; Hallman M; Strayer D; Edwards DK; Gluck L
J Clin Invest; 1983 Aug; 72(2):656-66. PubMed ID: 6603478
[TBL] [Abstract][Full Text] [Related]
16. Influence of plasma proteinase inhibitors and the secretory leucocyte proteinase inhibitor on pancreatic elastase-induced degradation of some plasma proteins.
Håkansson HO; Ohlsson K
Gastroenterol Jpn; 1992 Oct; 27(5):652-6. PubMed ID: 1358738
[TBL] [Abstract][Full Text] [Related]
17. Proteinase-antiproteinase balance in tracheal aspirates from neonates.
Sluis KB; Darlow BA; Vissers MC; Winterbourn CC
Eur Respir J; 1994 Feb; 7(2):251-9. PubMed ID: 7909297
[TBL] [Abstract][Full Text] [Related]
18. Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.
Björk P; Axelsson L; Bergenfeldt M; Ohlsson K
Scand J Clin Lab Invest; 1988 Apr; 48(2):205-11. PubMed ID: 2451859
[TBL] [Abstract][Full Text] [Related]
19. Structure, function, and control of neutrophil proteinases.
Travis J
Am J Med; 1988 Jun; 84(6A):37-42. PubMed ID: 2454577
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte protease inhibition in acute and chronic middle ear effusion.
Carlsson B; Lundberg C; Ohlsson K
Acta Otolaryngol; 1983; 95(3-4):341-9. PubMed ID: 6188318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
